Quadrupole Mass Spectrometer

Added: Apr 10, 2018 3:35 pm The purpose of this amendment is to extend the solicitation response deadline by ten (10) days and to change the Point of Contacts as Follows:

1.) Response deadline:
From: 04/13/2018 3:00PM Eastern Time
To: 04/23/2018 3:00PM Eastern Time

2.) Points of Contacts:
From: Susan Bechtel

To: Christopher R. McGucken, Christopher.McGucken@fda.hhs.gov
and
To: Matthew J. Bucher, Matthew.Bucher@fda.hhs.gov


ALL QUOTES SUBMITTED IN RESPONSE TO THIS SOLICIATION SHALL BE SUBMITTED TO BOTH THE REVISED POC's LISTED ABOVE.

Added: Apr 02, 2018 4:35 pm This request is the purchase of a new bench-top triple quadrupole mass spectrometer MS system coupled to ultra-performance liquid chromatographic system. The MS system shall provide superior sensitivity, up to 6 orders of magnitude (dynamic range), an ESI and APCI source, and software for instrument control, data acquisition and analysis of small and large molecules and biomarkers verification. The increase in sensitivity with broad working mass range allow us to measure proteins involved in drug metabolism and transport in tissue samples through select monitoring of unique peptides thus allowing us to quantify proteins in drug metabolism and transport studies associated with drug response and toxicity.

See attached RFQ for specifics.